Industry links with patient organisations.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Commercial influences on patient and public involvement: a renewed call for research and action.Health promotion international · 2024
   Article
2. Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2024
   Article
3. Risky business? Pharmaceutical industry sponsorship of health consumer groups.Australian prescriber · 2021
   Article
4. Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016).BMJ open · 2020
   Article
5. Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.PloS one · 2020
   Article
6. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.BMJ (Clinical research ed.) · 2019
   Article
7. Exposing drug industry funding of UK patient organisations.BMJ (Clinical research ed.) · 2019
   Article
8. Industry Support of Patient Advocacy Organizations: The Case for an Extension of the Sunshine Act Provisions of the Affordable Care Act.American journal of public health · 2018
   Article
9. How to incorporate patient and public perspectives into the design and conduct of research.F1000Research · 2018
   Article
10. Bad Medicine: The medical untouchables.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Article

Corrections and comments

• Comment on
  Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.2017
• Comment on
  Conflicts of Interest for Patient-Advocacy Organizations.2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as